Literature DB >> 18761113

Combined effects of recombinant human BMP-7 (rhBMP-7) and parathyroid hormone (1-34) in metaphyseal bone healing.

Elise F Morgan1, Zachary D Mason, Gavin Bishop, A David Davis, Nathan A Wigner, Louis C Gerstenfeld, Thomas A Einhorn.   

Abstract

Fracture healing involves multiple stages of repair and coordinated actions of multiple cell types. Consequently, it may be possible to enhance healing through treatment strategies that target more than one repair process or cell type. The goal of this study was to determine the combined effects of recombinant human bone morphogenetic protein 7 (rhBMP-7) and parathyroid hormone (PTH(1-34)) on metaphyseal bone healing. A wedge-shaped defect was created in the lateral aspect of the distal tibia in female New Zealand white rabbits (n=64) and was filled with tricalcium phosphate (TCP). Animals were assigned to four groups: 1) BMP-7 and PTH; 2) BMP-7; 3) PTH; and 4) control (TCP alone). In groups 1 and 2, 200 microg rhBMP-7 was incorporated into the TCP. Animals received daily subcutaneous injections of 10 microg/kg PTH(1-34) (groups 1 and 3) or saline (groups 2 and 4). Healing at 4 weeks was assessed using micro-computed tomography, histology, immunohistochemistry, and mechanical testing. Combined treatment with rhBMP-7 and PTH resulted in increased callus total volume (TV), mineralized volume (BV), average cross-sectional area, and bone mineral content (BMC) as compared to the control group (p<0.02). BV and BMC were also higher in the combined treatment group as compared to the BMP-7 group (p<0.02); however, tissue mineral density was highest in the BMP-7 group (p=0.002). New bone formation in the BMP-7 group was largely restricted to the defect site, while PTH promoted bone formation throughout the defect and surrounding regions. Combined treatment led to greater quantities of woven trabecular bone, increased trabecular thickness, decreased trabecular separation (p<0.04), and a trend towards increased numbers of osteoclasts (p=0.09). Combined treatment also resulted in increased torsional rigidity and compressive strength as compared to the control and BMP-7 groups (p<0.001). These results suggest that the improvements in mechanical function obtained with the combined treatment resulted from differing biological activities of rhBMP-7 and PTH. While the activities of rhBMP-7 appeared to be strictly anabolic, those of PTH appeared to work in the context of coupled remodeling. The combination of both agents led to greater bone volume as well as better microstructural organization and integration of this bone with the surrounding tissues.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18761113     DOI: 10.1016/j.bone.2008.07.251

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  20 in total

Review 1.  Anabolic agents: what is beyond osteoporosis?

Authors:  Y Liu; A E Levack; E Marty; O Or; B P Samuels; M Redko; J M Lane
Journal:  Osteoporos Int       Date:  2018-04-07       Impact factor: 4.507

2.  Tribute to Dr. Marshall Urist: musculoskeletal growth factors: editorial comment.

Authors:  Feza Korkusuz
Journal:  Clin Orthop Relat Res       Date:  2009-12       Impact factor: 4.176

Review 3.  Fracture healing: mechanisms and interventions.

Authors:  Thomas A Einhorn; Louis C Gerstenfeld
Journal:  Nat Rev Rheumatol       Date:  2014-09-30       Impact factor: 20.543

Review 4.  Mechanisms Underlying Normal Fracture Healing and Risk Factors for Delayed Healing.

Authors:  Cheng Cheng; Dolores Shoback
Journal:  Curr Osteoporos Rep       Date:  2019-02       Impact factor: 5.096

5.  Fracture healing and drug therapies in osteoporosis.

Authors:  Amy Hoang-Kim; Letizia Gelsomini; Deianira Luciani; Antonio Moroni; Sandro Giannini
Journal:  Clin Cases Miner Bone Metab       Date:  2009-05

6.  Bone regeneration potential of a soybean-based filler: experimental study in a rabbit cancellous bone defects.

Authors:  Gianluca Giavaresi; Milena Fini; Jonathan Salvage; Nicolò Nicoli Aldini; Roberto Giardino; Luigi Ambrosio; Luigi Nicolais; Matteo Santin
Journal:  J Mater Sci Mater Med       Date:  2009-09-22       Impact factor: 3.896

Review 7.  Growth factors in bone repair.

Authors:  Valentina Devescovi; Elisa Leonardi; Gabriela Ciapetti; Elisabetta Cenni
Journal:  Chir Organi Mov       Date:  2008-11-29

8.  Potent anti-inflammatory agent escin does not affect the healing of tibia fracture and abdominal wound in an animal model.

Authors:  Leiming Zhang; Hongsheng Wang; Tian Wang; Na Jiang; Pengfei Yu; Feiyan Liu; Yating Chong; Fenghua Fu
Journal:  Exp Ther Med       Date:  2012-01-31       Impact factor: 2.447

9.  Do estrogen and alendronate improve metaphyseal fracture healing when applied as osteoporosis prophylaxis?

Authors:  Leila Kolios; Ann Kristin Hoerster; Stephan Sehmisch; Marie Christin Malcherek; Thomas Rack; Mohammed Tezval; Dana Seidlova-Wuttke; Wolfgang Wuttke; Klaus Michael Stuermer; Ewa Klara Stuermer
Journal:  Calcif Tissue Int       Date:  2009-12-01       Impact factor: 4.333

10.  Deleterious effects of intermittent recombinant parathyroid hormone on cartilage formation in a rabbit microfracture model: a preliminary study.

Authors:  Brian T Feeley; Steven B Doty; Zlatko Devcic; Russell F Warren; Joseph M Lane
Journal:  HSS J       Date:  2009-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.